logo

For the Inventor, By the Inventor

Tianjin, China

Weiren Xu

This inventor holds 10 USPTO granted patents and 2 published patent applications and 7 EPO patents. Top assignees: Tianjin Institute of Pharmaceutical Research, Tianjin Institute of Pharmaceutical Research Co., Ltd.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiren Xu. Retrieved from https://idiyas.com/inventor/weiren-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 60.0

 

Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal6 out of 10 
 
Tianjin Institute of Pharmaceutical Research
 patents
silverMedal4 out of 5 
 
Tianjin Institute of Pharmaceutical Research Co., Ltd.
 patents

Years Active: 2010-2022

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 11466025 - Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof (2022-10-11),
2. 11149013 - Crystal form of urate transporter 1 inhibitor and preparation method and use thereof (2021-10-19),
3. 11091448 - Method for preparing urate transporter 1 inhibitor (2021-08-17),
4. 10584104 - Carboxylic acid URAT1 inhibitor containing diarylmethane structure, preparation method and use thereof (2020-03-10),
5. 10294259 - Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof (2019-05-21),
6. 9505734 - Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof (2016-11-29),
7. 9062087 - Phenyl C-glucoside derivatives, preparation methods and uses thereof (2015-06-23),
8. 8835134 - Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof (2014-09-16),
9. 8481577 - Amide thiazole derivative, preparation method and uses thereof (2013-07-09),
10. 7790759 - Glycyrrhetinic acid-30-amide derivatives and their use (2010-09-07),

Title: Weiren Xu: Innovator in Pharmaceutical Research

Introduction

Weiren Xu is a prominent inventor based in Tianjin, China, known for his significant contributions to pharmaceutical research. With a total of 10 patents to his name, he has made remarkable advancements in the field of drug development.

Latest Patents

One of his latest patents is focused on thienopyridine derivatives containing unsaturated aliphatic olefinic bonds. This invention provides a compound with a specific structure, a preparation method, and its use in pharmaceutical compositions. The compound addresses critical issues such as clopidogrel resistance and severe hemorrhagic side effects, offering a potential solution with improved stability and therapeutic effects. Another notable patent involves a crystal form of a urate transporter 1 inhibitor, which enhances the purity and storage stability of the compound, making it suitable as a pharmaceutical raw material.

Career Highlights

Weiren Xu has worked at the Tianjin Institute of Pharmaceutical Research and the Tianjin Institute of Pharmaceutical Research Co., Ltd. His work has been instrumental in developing innovative pharmaceutical solutions that address various medical challenges.

Collaborations

Throughout his career, Weiren has collaborated with notable colleagues, including Lida Tang and Yuli Wang. Their combined expertise has contributed to the success of various research projects and patent developments.

Conclusion

Weiren Xu's contributions to pharmaceutical research and his innovative patents highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in drug development and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…